Blotter

FIRM Act would require some foreign scientists to register as foreign agents

Sarina Neote
March 12, 2020

In late January, U.S. Rep. Seth Moulton, D-Mass., introduced the Foreign Influence Registration Modernization Act, or the FIRM Act, to the U.S. House of Representatives. This bill would require people in pursuit of academic or scholarly work who represent foreign governments that engage in human rights abuses to register as foreign agents. If enacted, this legislation would affect some foreign scientists collaborating with U.S. scientists on federally funded research.

With this bill, Moulton seeks to amend the Foreign Agents Registration Act of 1938, called FARA for short. That act was originally intended, as Moulton put it in an article in Time magazine, to “counter the rise of fascism in America as foreign operatives were spreading disinformation and propaganda.” FARA requires individuals who represent the interests of foreign powers in a political capacity or quasi political capacity to disclose their relationships with the foreign governments and register as foreign agents.

Moulton’s bill, meanwhile, is intended to modernize the disclosure requirements for foreign agents by digitizing the process; it also would narrow the definition of a foreign agent to an individual representing a foreign government, instead of “foreign powers.” In doing so, this act changes the exemption for scientists; under FARA, individuals in scholarly or scientific pursuit representing a foreign government do not have to register as foreign agents. But under the FIRM Act, any scientist representing a foreign government or receiving financial contributions directly from a foreign government that has committed human rights abuses would have to register as a foreign agent.

This would include any scientists who participate in foreign talent-recruitment programs, such as China’s Ten Thousand Program, which has been at the center of violations of research integrity. Moulton has insisted that “China has an all-out government effort to infiltrate our national security and education institutions.”

In recent years, several foreign researchers have failed to disclose funding they receive from China or have violated the confidentiality of peer review at the National Institutes of Health. The NIH has investigated at least 180 scientists at more than 65 institutions since 2018 for “violating policies requiring grantees to report their foreign ties.

The NIH has been working closely with the FBI to conduct these investigations and has referred several cases of alleged foreign influence in federally funded research to the FBI.

The FBI also has urged universities to review research conducted by Chinese scientists that could have defense applications. Since 2018, federal investigators have visited 10 institutions with a list of Chinese research institutions and/or companies for the university to monitor for research violations. The FBI also has been offering briefings to universities about foreign influences on scientific research conducted in the U.S.

The FIRM Act has been referred to the House judiciary committee. A month after the bill was introduced, U.S. Rep. Banks, R-Ind., co-sponsored the bill, indicating that the bill is gaining some traction. The judiciary committee will decide to whether to revise the bill or recommend a vote by the full House.

The ASBMB will continue track and report on the progress of this bill and other developments regarding foreign influence in U.S. scientific research.

Sarina Neote

Sarina Neote is ASBMB's science policy manager.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

ASBMB responds to proposal for new health research agency
Blotter

ASBMB responds to proposal for new health research agency

July 27, 2021

Society recommends keeping funding for ARPA-H separate from that of other agencies and developing a unique strategic plan.

Why is the FDA funded in part by the companies it regulates?
Funding

Why is the FDA funded in part by the companies it regulates?

July 4, 2021

The U.S. Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

ASBMB calls for changes to Title IX policy
Blotter

ASBMB calls for changes to Title IX policy

June 16, 2021

Society urges Department of Education to revise rule created by Trump administration.

Rethinking the NIH review system
Reimagining

Rethinking the NIH review system

June 10, 2021

Proposals for change include a tiered grant funding system, tweaks to scoring and criteria, internal reviews and a continuous submission system.

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire
News

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire

June 9, 2021

Where the coronavirus originated remains a mystery, and the Chinese are bucking demands to let investigators see more.

Two years of the DOJ’s China Initiative
Blotter

Two years of the DOJ’s China Initiative

April 14, 2021

Despite the agency’s intense scrutiny of scientists at academic institutions, few have been convicted, and none has been accused of economic espionage.